1 We have compared the binding properties of several hexocyclium and sila-hexocyclium derivatives to muscarinic Ml receptors (in rat brain, human neuroblastoma (NB-OK I) cells and calf superior cervical ganglia), rat heart M2 receptors, rat pancreas M3 receptors and M4 receptors in rat striatum, with their functional antimuscarinic properties in rabbit vas deferens (M l /M 4 -like), guinea-pig atria (M 2 ), and guinea-pig ileum (M3) muscarinic receptors. 2 Si la-substitution (C/Si exchange) of hexocyclium (~ sila-hexocyclium) and demethyl-hexocyclium (~ demethyl-sila-hexocyclium) did not significantly affect their affinities for muscarinic receptors. By contrast, si la-substitution of o-methoxy-hexocyclium increased its affinity 2 to 3 fold for all the muscarinic receptor subtypes studied. 3 The p-fluoro-and p-chloro-derivatives of sila-hexocyclium had lower affinities than the parent compound at the four receptor subtypes, in binding and pharmacological studies. 4 In binding studies, o-methoxy-sila-hexocyclium (Ml = M4 ~ M3 ~ M 2 ) had a much lower affinity than sila-hexocyclium for the four receptor subtypes, and discriminated the receptor subtypes more poorly than sila-hexocyclium (Ml = M3> M4> M2)' This is in marked contrast with the very clear selectivity of o-methoxy-sila-hexocyclium for the prejunctional MtlM 4 -like heteroreceptors in rabbit vas deferens. 5 The tertiary amines demethyl-hexocyclium, demethyl-sila-hexocyclium and demethyl-o-methoxy-silahexocyclium had 10 to 30 fold lower affinities than the corresponding quaternary ammonium derivatives.
Introduction
Following the discovery that pirenzepine is able to discriminate several muscarinic receptor binding sites (Hammer et al., 1980) , the subclassification and characterization of various muscarinic receptor subtypes has aroused increasing interest. Molecular biology studies suggest that at least five genes encoding muscarinic receptor subtypes (ml-m5) are expressed in mammalian tissues (see Hulme et al., 1990; Levine & Birdsall, 1993) . Functional and binding experiments revealed the existence of four different native subtypes, termed M l -M 4 . Comparison of the radioligand binding properties and functional coupling of the native M l -M 4 receptors with those of the expressed ml-m4 proteins showed a good correlation (Hulme et al., 1990; Lazareno et al., 1990; Waelbroeck et al., 1990; Dorje et al., 1991; Levine & Birdsall, 1993) .
Although several drugs have been reported to discriminate the Ml from M 2 , M3 and M. receptors in binding and/or functional studies, most of these drugs possess tertiary amino groups. Their binding properties, like those of pirenzepine, might therefore be strongly pH-dependent (Barlow & Chan, 1982) , a factor which may complicate the identification of receptor sUbtypes. It was interesting, therefore, that a quaternary ammonium compound, o-methoxy-sila-hexocyclium, was found to have very clear Ml selectivity in functional studies Boddeke et al., 1989; Polidori et al., 1990) .
The goal of the present study was to evaluate the structural requirements for binding of the carbon/silicon I Author for correspondence. 2 Present address: Preclinical Research, Sandoz Pharma AG, CH-4002 Basle, Switzerland analogues hexocyclium and sila-hexocyclium and related compounds ( Figure 1 ) to Mlo cardiac M 2 , glandular/smooth muscle M3 and brain M4 sites. To achieve this goal, we analysed the binding properties of the compounds to PH]-pirenzepine-Iabelled Ml sites in rat brain cortex, PH]-telenzepine-Iabelled Ml sites in calf superior cervical ganglia (Feifel et al., 1991) (Waelbroeck et al., 1987b; , [3H]-NMS-labelled rat cardiac M2 sites (Waelbroeck et al., 1987a) , PH]-NMS-Iabelled rat pancreas M3 sites (Waelbroeck et al., 1987a) and [3H]-NMS-labelled M4 sites in rat striatum, sites with a slow dissociation rate for NMS (Waelbroeck et al., 1987b; 1990) .
or [3H]-N-methyl-scopolamine ([3H]_ NMS)-Iabelled NB-OK I (M l ) sites
We compared the binding affinity profiles at these four receptor subtypes with the pharmacological properties of the compounds at prejunctional muscarinic heteroreceptors in rabbit vas deferens (Eltze, 1988; Eltze et al., 1988; Grimm et al., 1994; Lambrecht et al., 1993) , M2 receptors in guinea-pig atria, and M3 receptors in guinea-pig ileum (see review by Caulfield, 1993) .
The affinities of a number of antagonists for the prejunctional muscanmc receptors mediating inhibition of neurogenic contractions of rabbit vas deferens clearly indicate that these receptors are not the M 2 , M3 or m5 subtype (Eltze, 1988; Eltze et aI., 1988; Dorje et al., 1991; Grimm et al., 1994) . The most prominent features of these prejunctional inhibitory receptors are: (i) a high affinity for the Ml-selective antagonist pirenzepine (pA2 values = 8. 08-8.52; Lambrecht et al., 1989; Choo & Mitchelson, 1990; Micheletti et al., 1990a; Dorje et al., 1990; Eltze et al., 1993; Sagrada et al., 1993) ; (ii) a high affinity for the M 2 /M 4 -selective antagonist himbacine (pA2 values = 8. 5-8.17; Dorje et al., 1990; Eltze et al., 1993; Sagrada et al., 1993) ; and (iii) a low affinity for methoctramine (pA2 value = 6.85; Lambrecht et al., 1989) . It is also worth noting that there is immunoreactivity to specific anti-m 1 receptor antibodies, but not to anti-m4 antibodies, in rabbit vas deferens (Dorje et al., 1991) . Thus, we are left with arguments for and against the presence of inhibitory muscarinic Ml and M4 heteroreceptors in rabbit vas deferens. Perhaps the data may be reconciled by multiple, Ml and M 4 , prejunctional muscarinic receptors.
Further experiments are needed to clarify this issue. To reflect this lack of final definition of the prejunctional rabbit vas deferens receptor subtype, in this paper we will use the term MdM4-like for these receptors.
Preliminary accounts of this study have been communicated to the German Society for Pharmacology and Toxicology, Hamburg, September 1988 and to the IUPHAR, Amsterdam, July 1990 (Feifel et al., 1990) .
Methods

Radioligand binding experiments: general considerations
Protein concentrations were determined according to Lowry et al. (1951) , using bovine serum albumin as standard. Male Wistar albino rats were killed by decapitation and the brain, heart or pancreas immediately removed. Calf superior cervical ganglia were obtained from a regional slaughterhouse and brought into the laboratory within 70 min. NB-OK 1 cells were cultured as previously described (Waelbroeck et al., 1988) , in RPMI 1640 medium enriched with 10% foetal calf serum, 100 units ml-1 penicillin and 100 I1g ml-1 streptomycin. All the following operations were performed at 4·C.
Preparation of the homogenates or crude membranes used for binding studies
M J receptors For [3HJ-NMS binding experiments, the NB-OK 1 cells were rinsed, harvested and centrifuged in 20 mM sodium phosphate buffer (pH 7.4) containing 150 mM NaCl and 1 mM EDT A, resuspended and homogenized in 20 mM Tris/HCI buffer (pH 7.5) enriched with 5 mM MgCh and stored in liquid nitrogen.
The rat brain cortex was homogenized in 15 ml of 20 mM Tris/HCl buffer (PH 7.5) enriched with 250 mM sucrose, in a glass-teflon homogenizer (7 up and down strokes). The resulting homogenate was stored in liquid nitrogen until use, and diluted 5 fold with the same buffer immediately before the experiment.
After separation of surrounding tissue, the calf superior cervical ganglia were minced with scissors and homogenized in ice-cold buffer solution (30 g tissue wet weight/lOO ml of 50 mM Tris/HCI buffer (pH 7.4) enriched with 120 mM NaCI and 5 mM MgCh), with an Ultra-Turrax (maximal speed, for 2 x 30 s). The homogenate was centrifuged at 160 g for 10 min, and the pellet was ground a second time and processed as before. The supernatants were combined and centrifuged for I h at 100,000 g. The pellets (corresponding to 20% of the original wet weight of the original tissue) were stored at -20·C until use. For binding studies, the pellets were resuspended in ice-cold buffer with a Potter-Elvejhem homogenizer.
M2 receptors
The rat heart was rinsed in isotonic NaCl, then homogenized in 2.5 ml of 20 mM Tris/HCI buffer (pH 7.5), enriched with 250 mM sucrose, with an UltraTurrax (maximal speed, for 5 s) followed by addition of 12.5 ml of the same buffer, 7 up and down strokes with a glass-teflon homogenizer and filtration on 2 layers of medical gauze.
M3 receptors
The rat pancreas was minced with scissors and homogenized with a glass-teflon homogenizer (7 up and down strokes) in 8 ml of 300 mM sucrose enriched with 0.2 mg ml-1 bacitracin and 500 kallikrein inhibitor units (KIU) ml-1 of trasylol. The resulting homogenate was immediately filtered over two layers of medical gauze and diluted 11 fold with the incubation buffer (66 mM sodium phosphate buffer, pH 7.4, enriched with 2.6 mM MgCh and with 13 mgml-1 bovine serum albumin, 0.24mgml-1 bacitracin and 600 KIU ml-1 of trasylol).
M4 receptors
Rat striatum homogenates were prepared in 2 ml of 20 mM Tris/HCI buffer (pH 7.5), enriched with 250 mM sucrose, and stored in liquid nitrogen until use. The homogenates were diluted 20 fold with the homogenization buffer, immediately before the incubation with fH]-NMS.
Binding studies
Most binding studies were performed at 25T, at equilibrium, in a 50 mM sodium phosphate buffer (pH 7. (Waelbroeck et al., 1987b; 1990) . We preincubated 80111 of the homogenate (equivalent to about 30 I1g protein) in a total volume of 1.2 ml, in the presence of [3HJ-NMS and unlabelled drugs. A 2 h preincubation period allowed equilibrium binding. We then added II1M atropine and allowed tracer dissociation for 35 min before filtration. This procedure allowed us to investigate tracer binding to the striatum M4 sites. The tracer concentration used in these experiments was 0.25 nM.
The incubations were stopped by addition of 2 ml ice-cold filtration buffer (50 mM sodium phosphate buffer, pH 7.4). Bound and free tracer were immediately separated by filtration on glass fibre GFC filters presoaked overnight in 0.05% polyethyleneimine. The samples were rinsed three times with filtration buffer. The filters were then dried, and the bound radioactivity counted by liquid scintillation. Non specific [3HJ-telenzepine, fHJ-NMS or fH]-pirenzepine binding was defined as tracer bound in the presence of 10 I1M atropine.
For more experimental details, see Waelbroeck et al. (1987a,b; 1990) and Feifel et al. (1991) .
Analysis of binding data
All competition curves were repeated three times in duplicate. IC so values were determined by a computer-aided procedure described by Richardson & Humrich (1984) The standard deviations of p~ values were equal to or below 0.1 log unit.
Pharmacological experiments
Rabbit vas deferens Male New Zealand white rabbits (2.5-3.0 kg) were killed by i.v. injection of 120 mg kg-\ pentobarbitone sodium. The vasa deferentia were excised, dissected free of connective tissue and divided into four segments of approximately 1.5 cm length. The preparations were set up in 7 ml organ baths containing modified Krebs buffer which consisted of (mM): NaCl 118, KCl 4.7, CaCl 2 2.5, MgS04 0.6, KH 2 P0 4 1.2, NaHC0 3 25.0 and ( + )-glucose 11.1; I/lM yohimbine was included to block Clz-adrenoceptors. The bathing fluid was maintained at pH 7.4, 31 DC, and aerated with 95% 0 2 /5% CO 2 . A basal tension of 750 mg was applied. After a 30 min equilibration period, isometric twitch contractions were elicited by electrical field stimulation (0.05 Hz, 0.5 ms, 30 V) with platinum electrodes. These effects were concentration-dependently inhibited by the M\ receptor agonists 4-(3-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343) and 4-(4-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium iodide (4-Cl-McN-A-343) (Eltze, 1988; Eltze et al., 1988; Boddeke, 1991; Lambrecht et al., 1993) . The neurogenic contractions were measured by a force-displacement transducer connected to a Hellige amplifier and a Rikadenki polygraph.
Guinea-pig atria and ileum
Adult guinea-pigs of either sex were killed by cervical dislocation and the organs required were removed. Left atria and strips of ileal longitudinal smooth muscle of 1.5 cm length (Paton & Zar, 1968) were set up in 6 ml organ baths, under 500 mg tension, in oxygenated (95% 0 2 /5% CO 2 ) Tyrode solution, composed of (mM): NaCl 137, KCl 2.7, CaCh 1.8, MgCh 1.05, NaHC0 3 11.9, NaH 2 P0 4 0.42 and (+ )-glucose 5.6. All experiments were ANTAGONISTS AT MUSCARINIC RECEPTOR SUBTYPES 587 conducted at 32"C (PH 7.4). The agonist used was arecaidine propargyl ester (Mutschler & Lambrecht, 1984; Barlow & Weston-Smith, 1985; Lambrecht et al., 1993) . Left atria were electrically paced by means of platinum electrodes (2 Hz, 3 ms duration, supramaximal Voltage). Atrial responses to the agonist were measured as changes in isometric tension, and these effects were expressed as the percentage inhibition of the force of contraction. Responses of ileal longitudinal smooth muscle strips to arecaidine propargyl ester were measured as isotonic contractions. The effects in atria and ileum were recorded as with the rabbit vas deferens.
Antagonist affinities
After 1 h equilibration, concentration-response curves were obtained by cumulative addition of the agonists (Van Rossum, 1963) . When these responses were constant, concentration-response curves were repeated in the presence of at least 3 concentrations (in most cases, log interval = 0.48) of antagonists, allowing 15-45 min equilibration time. Each concentration of antagonist was tested 3 to 5 times and the ratios of agonist molar EC 50 values obtained in the presence and absence of antagonists were calculated. The slopes of the Arunlakshana-Schild plots (Arunlakshana & Schild, 1959) were determined by linear regression using the method of least squares. pA2 values were estimated by fitting to the data the best straight line with a slope of unity (Arunlakshana & Schild, 1959; Tallarida et al., 1979) .
To assess whether o-methoxy-sila-hexocyclium (3b) had actions at a site in addition to that occupied by the M\-selective agonist, McN-A-343, in rabbit vas deferens, combination antagonist studies were performed on the basis of dose-ratio analysis (Paton & Rang, 1965) . The concentrationresponse curves to McN-A-343 in these experiments were obtained under control conditions and then in the presence of compound 3b (50/lM) or pirenzepine (50/lM) alone or with the two antagonists combined. The contact time for pirenzepine and 3b was always 30 min. The experimental data for individual antagonist applications were used to calculate dose-ratios (DR) expected for the combination for two models: expected single-site = DR\ + DR2 -1 and expected independent sites = DR\ x DR 2 . These dose-ratios were compared with the experimentally observed combined mean doseratio.
Data analysis
All data are presented as means ± s.e.mean of the indicated number (n) of experiments. Linear regression analyses were 7.9 7.9 6.6 7.4 8.0 3a o-Methoxy-hexocyclium 6.8 6.8 5.9 6.2 6.8 3b o-Methoxy-sila-hexocyclium 7.1 7.1 6.9 6.3 6.6 7.0 4 Demethyl-o-methoxy-sila-hexocyclium 6.5 6.4 6.7 5.3 5.6 6.2 5 p-Fluoro-sila-hexocyclium 7.9 7.9 7.8 6.9 7.3 7.9 6 p-Chloro-sila-hexocyclium 7.4 7.5 7.4 6.4 7.0 7.1 "The standard deviations of the pKi values were typically ± 0.1 log unit, always below 0.15 log unit. The Hill coefficients varied between 0.95 and 1.05 (standard deviation ± 0.1) except for the [3Hl-pirenzepine/la/lb competition curves in brain cortex (Hill coefficients of 0.85 were obtained for these compounds).
bThe pKi values of these compounds in NB-OK 1 cells, pancreas and heart homogenates have been published previously . cThe competition curves were biphasic (see text). The pKi values indicated correspond to the major 'subclass' of binding sites (85 to 90% of tracer binding).
carried out by the method of least squares (Tallarida et ai., 1979) . Differences between mean values were tested for statistical significance by Student's t test; P<0.05 was accepted as being significant. (Mutschler & Hultzsch, 1973) , hexocyclium (la; as methyl sulphate; Zaugg et ai., 1958) , sila-hexocyclium (Ib as methyl sulphate; Tacke et al., 1989a) , demethyl-hexocyclium (2a; Zaugg et al., 1958) , demethyl-sila-hexocyclium (2b; as dihydrochloride), o-methoxy-hexocyclium (3a; as methyl sulphate; Strohmann, 1990) , o-methoxy-sila-hexocyclium (3b; as methyl sulphate; Tacke et al., 1 989b) and demethyl-omethoxy-sila-hexocyclium (4; as dihydrochloride; Tacke et ai., 1989b) were synthesized in our laboratories according to the literature. p-Fluoro-sila-hexocyclium (5; as methyl sulphate; m.p. 108°C) and p-chloro-sila-hexocyclium (6; as methyl sulphate; m.p. 149-150°C) were prepared by analogy to the parent compound sila-hexocyclium (Ib; Tacke et al., 1989b) . Compounds 5 and 6 were characterized by IH-NMR,
13C-NMR and El-MS measurements as well as by elemental analyses.
Compounds la/lb-3a/3b and 4-6 (see Figure I ) possess a centre of chirality, the carbinol and silanol, respectively, carbon and silicon atom, and therefore exist in two enantiomers. In this study, all compounds were used as racemates.
Results
Radioligand binding studies
All compounds inhibited tracer binding to muscarinic receptors. Most competition curves did not deviate significantly from results expected for competitive inhibition of tracer binding to a single receptor (see for example Figures 2 and  3) . The only exceptions to this rule were the [3H]-pirenzepine/ hexocyclium (la) and [lH]-pirenzepine/sila-hexocyclium (Ib) competition curves in rat cortex (Figure 2 ): these two quaternary compounds inhibited [3H]-pirenzepine binding to 85 or 90% of the receptors with a high affinity, and to 10 or 15% of the receptor with a very low affinity (Figure 2) . However, the affinities of compounds la/lb-3a/3b and 4-6 for the majority of Ml receptors in rat cortex were very similar to that for Ml receptors in NB-OK 1 cells and calf superior cervical ganglia (Table I, Figures 2 and 3) . The structureaffinity relationships of the hexocyclium and sila-hexocyclium derivatives at each receptor subtype are summarized in Table  1 and Figure 4 .
The hexocyclium and sila-hexocyclium derivatives studied in this work, like the parent compounds hexocyclium and sila-hexocyclium, had a clear preference for M 1 , M3 and M4 over M2 receptors (Table 1) . The same affinity. profile (Ml ~M3~M4> M 2 ) has been reported for hexocyclium as well as for sila-hexocyclium at cloned muscarinic ml-~ receptors expressed in CHO-Kl cells (Buckley et ai., 1989) . Figure I Structural formulas of the compounds studied: hexocyclium (la) and sila-hexocyc1ium (Ib), demethyl-hexocyclium (2a) and demethyl-sila-hexocyc1ium (2b), o-methoxy-hexocyc1ium (3a) and o-methoxy-sila-hexocyc1ium (3b), demethyl-o-methoxy-silahexocyc1ium (4), p-fluoro-sila-hexocyc1ium (5) and p-chloro-sila-hexocyc1ium (6). All compounds possess a centre of chirality and therefore exist in two enantiomers. In this study, they were used as racemates.
Pharmacological studies
All compounds antagonized the inhibition of neurogenic contractions of rabbit vas deferens by McN-A-343 or 4-CI-McN-A-343 as well as the negative inotropic effects in electrically stimulated guinea-pig left atria and the contractions of the guinea-pig ileum to arecaidine propargyl ester. This is shown for o-methoxy-sila-hexocyclium (3b) in Figure 5 . With the exception of demethyl-o-methoxy-sila-hexocycliurn (4) in atria (Table 2) , there was a concentration-dependent parallel shift to the right of agonist dose-response curves without either the basal tension or the maximal responses being affected. The Schild plots were linear throughout the 100 -,: Flpre 2 [3H]-pirenzepine competitIOn curves in rat cortex were obtained as explained in Methods, using la or Ib (e) (the experimental data were within 2% of the means; we therefore used a single symbol for the two compounds), 3a (Ll) and 3b (.&). 
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antagonist concentration-range studied, and slopes were not significantly different from unity (P> 0.05), except for 0-methoxy-sila-hexocyclium (3b) at M2 receptors ( Figure 5 and Table 2 ). The pA2 value of 3b in guinea-pig atria (6.41) might therefore be regarded as a purely experimental quantity. However, the binding affinity of 3b to M2 receptors in rat heart (pKi = 6.3; Table 1 ) was very similar to that obtained in functional studies in guinea-pig atria. In the radioligand binding studies (Figure 3 ), competition curves with 3b in rat heart homogenates did not deviate significantly from results expected for competitive inhibition of [3H]-NMS binding at a single binding site. Thus, compounds la/lb-3a/3b and 4-6 were apparently simple competitive antagonists in the preparations studied. The pA2 values are shown in Table 2 .
Hexocyclium (la), sila-hexocyclium (lb) and the derivatives studied in this work had a greater affinity for the MdM4-like heteroreceptors in rabbit vas deferens as compared to guinea-pig (M 2 ) receptors ( Table 2 ). Most of the compounds also had a higher affinity for guinea-pig ileum M3 receptors (Table 2) . o-Methoxy-sila-hexocyclium (3b) had a different selectivity pattern: it had a 30 fold and 100 fold higher affinity for MdM4-like receptors in rabbit vas deferens over M3 receptors in guinea-pig ileum and M2 receptors in guinea-pig atria, respectively (Table 2) .
To investigate whether o-methoxy-sila-hexocyclium (3b) was interacting solely at the muscarinic receptor in rabbit vas deferens occupied by the agonist McN-A-343, combination concentration-ratio experiments were undertaken with pirenzepine using the method of Paton & Rang (1965) .
The concentration-ratios, determined in separate tissues "Data taken from Waelbroeck et al. (1989) . bData taken from Lambrecht et al. (1988) .
CSignificantly different from unity (P < 0.05). dOnly one concentration (10 I'M: n = 5) was investigated due to the negative inotropic effects of the compound itself at higher concentrations. The pA2 values were therefore determined from the individual dose-ratios according to Tallarida et al. (1979) .
(n = 5) for pirenzepine (50 nM; DR, = 11.8 ::t 1.5, pA2 = 8.32 ± 0.05) and compound 3b (50 nM; DR2 = 7.4 ± 0.6, pA2 = 8.10 ± 0.01) were first ascertained. Again, in separate tissues (n = 5), the effect of compound 3b was determined in the presence of pirenzepine (DR = 18.3 ± 2.4). This combined mean dose-ratio obtained experimentally was very close to that calculated for the two antagonists acting by competing with the agonist for the receptor site (DR, + DR2 -I = 19.2). The results were not consistent (P<0.05, unpaired t test) with a multiplication of doseratios (DR, x DR2 = 87.0) which would be expected if the two antagonists interacted at independent sites.
Discussion
The native muscanmc receptors are currently divided, in binding and functional studies, into four subtypes (M 1 -M 4 ), the M, receptors being recognized by their higher affinity for pirenzepine (see, Hulme et al., 1990; Wae1broeck et al., 1990; Lazareno et al., 1990; Dorje et al., 1991; Doods et al., 1993; Lazareno & Birdsall, 1993; Levine & Birdsall, 1993) . As pointed out some years ago by Barlow & Chan (1982) , the fact that pirenzepine is a tertiary amine may lead to problems in determining its antimuscarinic potency. Indeed, titration of the amino group of pirenzepine by variation of the pH of the bath fluid affects markedly its affinity for muscarinic receptors in smooth muscle (Barlow & Chan, 1982) . o-Methoxy-sila-hexocyclium (3b) is the first M,-selective quaternary muscarinic antagonist in functional studies Boddeke et al., 1989; Polidori et al., 1990) . It has a large functional M, > M3 selectivity, and an even greater M, > M2 selectivity than pirenzepine.
With this in mind, we decided to measure its affinity for four muscarinic receptor subtypes, and to investigate the structure-activity relationships of various tertiary and quaternary hexocyclium and sila-hexocyclium derivatives (Figure 1 ) at different muscarinic receptor subtypes. These studies were also performed as a part of our systematic investigations on carbon/silicon bioisosterism (Tacke & Zilch, 1986; Tacke & Linoh, 1989; Wae1broeck et al., 1989) .
General considerations
In functional experiments, hexocyclium, sila-hexocyclium and their derivatives behaved as competitive muscarinic antagonists ( Figure 5 and Table 2) .
In binding studies, most of the competition curves were also compatible with competitive antagonism at a single site (Figures 2 and 3 ). Hexocyclium and sila-hexocyclium, however, recognized a small fraction (10-15%) of the [3H]_ pirenzepine-Iabelled receptors with a very low affinity ( Figure  2) . We observed the same type of competition curves with other quaternary antagonists having a high affinity (results not shown), using either [3H]-quinuclidinyl benzylate or fHlpirenzepine as tracer, i.e. two tertiary amines. As demonstrated by Ellis (1988) , this population of receptors with very low affinity for quaternary antagonists is not correlated with the MJ, M 2 , M3 or M4 receptor category. We are not aware of the existence of muscarinic receptors having (in functional studies) a comparable affinity profile. We therefore believe that this reflects the existence of binding sites accessible only through a hydrophobic barrier (for instance facing inside closed vesicles) (see Ellis, 1988) .
Structure-activity relationships
Sila-substitution of hexocyclium (la -+ lb) and demethylhexocyclium (2a -+ 2b) increased only slightly their affinities for the different muscarinic receptor subtypes (Wae1broeck et al., 1989) . The effect of sila-substitution on o-methoxyhexocyclium (3a -+ 3b) was somewhat greater (Figure 3a and Table 1 ). In binding studies, we observed a 2 to 3 fold greater affinity for 3b than for 3a, at all the muscarinic receptor subtypes (Table 1) . In pharmacological studies, 3b had a 15 fold higher affinity than 3a for the Mt/M 4 -like receptors in rabbit vas deferens ( Table 2) .
Demethylation of hexocyclium (la -+ 2a), sila-hexocyclium (lb-+2b) and o-methoxy-sila-hexocyclium (3b-+4) decreased affinities for all muscarinic receptor subtypes by at least 5 fold (Wae1broeck et al., 1989, and this work) . This very large effect cannot be explained solely by the stabilization of the positive charge on the quaternary ammonium group, and therefore suggests that this ammonium group fits in a hydrophobic pocket. Substitutions of the phenyl ring in the para-position (pfluoro-and p-chloro-derivatives, 5 and 6) and in the orthoposition (o-methoxy derivatives, 3a, 3b and 4) decreased the affinities of the respective parent drugs la, Ib and 2b at the four muscarinic receptor subtypes (Figure 4) . The affinity loss due to replacement of a hydrogen by a (small) fluorine atom varied between 5 and lO fold, depending on the receptor subtype studied. This suggested that the introduction of a fluorine atom not only induced steric repulsions between the phenyl group and the muscarinic binding site, but probably also modified the electronic properties of the whole phenyl ring (polarization), with unfavourable effects on the interaction with the muscarinic receptors.
In binding studies, the affinity loss due to introducing an o-methoxy group was very impressive (20 to 160 fold lower affinity). Binding to all subtypes was similarly affected by the modification (compare la-+3a, Ib-+3b, 2b-+4). In contrast, o-methoxy-sila-hexocyclium (3b) had a high potency in pharmacological experiments at Ml receptors (pA2 value of 8.31 in rat superior cervical ganglia, Lambrecht et aI., 1988; Boddeke et al., 1989) and at Mt/M 4 -like receptors in rabbit vas deferens (PA2 value = 8.39; this study).
neurogenic twitch contractions in rabbit vas aeferens in the absence (.; n = 12) and presence (n = 4) of 5 (e), 15 (~), 45 (+) and 300 (.6.) nM 3b. (b) Concentration-response curves for arecaidine propargyl ester-induced negative inotropy in guinea-pig atria in the absence (.; n = 6) and presence (n = 3) of 1 (e), 3 (~) and 10 (+) I'M 3b.
(c) Concentration-response curves for arecaidine propargyl esterinduced contractions in guinea-pig isolated ileum longitudinal smooth muscle in the absence (.; n = 6) and presence (n = 3) of 0.1 (e), 0.3 (~), 1 (+) and 3 (.6.)I'M 3b. (d) Schild regression from experiments in rabbit vas deferens (e), guinea-pig atria (.) and guinea-pig ileum smooth muscle (.6.).
Comparison of the binding and pharmacological properties
The affinities of the compounds studied in this work for the M2 receptors in rat heart (binding) and guinea-pig atria (functional studies) were very similar, both individually and in rank order (Figure 6 ). The affinities of the compounds for the M3 receptors in rat pancreas (binding) were consistently 2-3 fold less than in guinea-pig ileum (functional studies). This might explain part of the difference between the pKi and pA2 values of p-fluoro-sila-hexocyclium, which was 10 fold less potent in binding than in pharmacological studies on M3 receptors. The binding affinities of most of the compounds for Ml receptors in rat cortex, human neuroblastoma (NB-OK 1) cells and calf superior cervical ganglia were very close to their potencies obtained in pharmacological assays at Md M 4 -like heteroreceptors in rabbit vas deferens (Tables 1 and 2 and Figure 6 ). However, o-methoxy-sila-hexocyclium (3b) had a significantly lower affinity in binding compared to pharmacological assays (see also Lambrecht e"t al., 1988; Boddeke et al., 1989; Polidori et al., 1990; Lazareno & Birdsall, 1993) . This is particularly frustrating, since 0-methoxy-sila-hexocyclium had a remarkable selectivity, in pharmacological studies, for the rabbit vas deferens and rat superior cervical ganglia receptors. It is noteworthy that the pA2 values obtained for hexocyclium (la; 8.89), sila-hexocyclium (lb; 9.01), demethyl-sila-hexocyclium (2b; 7.73) and o-methoxy-sila-hexocyclium (3b; 8.39) in rabbit vas deferens (this study) were very similar to those at Ml receptors in rat superior cervical ganglia Lambrecht et al., 1988 : la = 8.8; lb = 9.6; 2b = 7.6; 3b = 8.3). In addition, the functional affinity of sila-hexocyclium (lb; pA2 = 8.78) for muscarinic M3 receptors in guinea-pig ileum (this study) was very close to reported M3 affinity data obtained in other tissues (rat parietal cells: Ki-[3H]-NMS binding = 3.2 nM; Ki-inositol phosphate production = 1.5 nM; Ki-[l4C]-aminopyrine accumulation = 2.7 nM; Pfeiffer et al., 1990b . Human HT-29 colon carcinoma cells: Kopp et al., 1989 . Human gastric mucosa: Ki-eH]-NMS binding = 5.6 nM; Pfeiffer et al., 1990a) .
We checked whether there could be an additional action of o-methoxy-sila-hexocyclium (other than on muscarinic receptors) in rabbit vas deferens by measuring the dose-ratio for McN-A-343 in the presence either of pirenzepine, of 3b, or of a combination of the two antagonists. The results confirmed that there is no additional action of compound 3b which cannot be accounted for by a competitive mechanism of action. We then decided to compare its binding properties to several different Ml binding sites of different origins (different animal species and different rat brain regions), in the hope of finding an assay system with Ml receptors having a high affinity for 3b. However, the binding properties of piren-zepine and of compounds 2a, 2b, 3a, 3b, ~ and 6 were identical in the three 'Ml' systems used for these studies (NB-OK 1 cells, rat brain cortex and calf superior cervical ganglia; Table 1 ). o-Methoxy-sila-hexocyclium (3b)/eH]-pirenzepine competition curves in three different rat brain regions (cortex, hippocampus and striatum) were also superimposable, and compatible with the existence of a single binding site with low affinity for 3b (unpublished results).
In the hope of identifying binding sites with a high affinity for 3b, we attempted to measure binding of racemic [3H]_0_ methoxy-sila-hexocyclium (70 Ci mmol-1 , lot 2423-148; developed in collaboration with Dr S. Hurt, New England Nuclear, Boston, MA, D.S.A.) to calf superior cervical ganglia. The experiments were carried out in the same way as for pH]-telenzepine binding, and revealed almost 95% nonspecific binding. It was therefore impossible to estimate this tracer's ([3H]-3b) affinity (unpublished results). It is possible that the data obtained in pharmacological studies reflect the properties of a very small receptor population, undetectable in binding studies. Further experiments are needed to clarify this issue. Here, it is noteworthy that the hexocyclium derivative N-iminomethyl-N-[(2-hydroxy-2-phenyl-2-cyclohexyl)-ethyl]piperazine (DAC 5945) has also been shown to display a high degree (204 fold M3 over M 2 ) of functional in vitro selectivity (pA2' M3/guinea-pig ileum = 8.56, pA2' MJ guinea-pig atria = 6.25, pA2' M 1 -M 4 -like/rabbit vas deferens = 7.97; Micheletti et al., 1990b; Lambrecht et al., unpublished results) , but the binding affinities of DAC 5945
(PKi values) to muscarinic Ml (8.3/8.3), M2 (7.5/7.4), M3 (8.4/7.9) and M4 receptors (8.4/8.6) differed only 16 fold (M4 over M 2 ; Doods et al., 1993; Waelbroeck et al., unpublished results) .
In conclusion, the present study shows that sila-substitution of o-methoxy-hexocyclium (3a ... 3b) had a greater effect on the binding properties than observed for the carbon/silicon pairs la/lb and 2a/2b: this might reflect differences in the relative importance of the bonds formed between the hydroxyl and phenyl groups and muscarinic receptors. Furthermore, the presence of a quaternary ammonium group is important for binding of antagonists of the hexocyclium/sila-hexocyclium type to muscarinic receptors. Substitution of the phenyl group in the 0-and ppositions of hexocyclium and sila-hexocyclium decreased affinity. Although o-methoxy-sila-hexocyclium was found to be remarkably Ml (MdM4-like)-selective in pharmacological studies, we were unable to confirm this property in binding studies.
